Free Trial

Brian Cheng - JPMorgan Chase & Co. Analyst Performance

This page shows the methodology used to calculate Brian Cheng's recommendation performance. Listed below are links to the research notes issued, the price targets issued by the analyst, and the stock's actual price 12 months from the date the research note was issued. These rankings are based on research reports from . Rankings are updated daily.

MarketBeat Analyst Ranking:
Average 12-Month ROI of Buy and Strong Buy Recommendations: ???%

CompanyReport DateReport Date Price12-Month
Price Target
Rating12-Month
Actual Price
12-Month
ROI
Details
Allogene Therapeutics, Inc. stock logo
ALLO
Allogene Therapeutics
8/4/2025$1.08Neutral???%???%
Blueprint Medicines Corporation stock logo
BPMC
Blueprint Medicines
6/2/2025$127.71$129.00Neutral???%???%
iTeos Therapeutics, Inc. stock logo
ITOS
iTeos Therapeutics
5/13/2025$8.02$8.00Neutral???%???%
CG Oncology, Inc. stock logo
CGON
CG Oncology
5/2/2025$27.74$41.00Overweight???%???%
Ascentage Pharma Group International - Unsponsored ADR stock logo
AAPG
Ascentage Pharma Group International
3/27/2025$18.37Overweight???%???%
iTeos Therapeutics, Inc. stock logo
ITOS
iTeos Therapeutics
3/6/2025$7.11$15.00Overweight???%???%
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
3/4/2025$38.50$57.00Overweight???%???%
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
2/28/2025$10.86$13.00Neutral???%???%
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
2/4/2025$37.66$53.00Overweight???%???%
Blueprint Medicines Corporation stock logo
BPMC
Blueprint Medicines
2/4/2025$112.35$129.00Overweight???%???%
CARGO Therapeutics, Inc. stock logo
CRGX
CARGO Therapeutics
1/30/2025$13.19Underweight???%???%
Poseida Therapeutics, Inc. stock logo
PSTX
Poseida Therapeutics
2/18/2022$3.93$24.00Buy???%???%
Poseida Therapeutics, Inc. stock logo
PSTX
Poseida Therapeutics
1/7/2022$6.27$24.00Overweight???%???%


Return to Analyst Rankings